Lund E - Search Results

1

Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry.

Dzeletovic S, Breuer O, Lund E, Diczfalusy U. Dzeletovic S, et al. Among authors: lund e. Anal Biochem. 1995 Feb 10;225(1):73-80. doi: 10.1006/abio.1995.1110. Anal Biochem. 1995. PMID: 7778789

2

Evidence that 24- and 27-hydroxylation are not involved in the cholesterol-induced down-regulation of hydroxymethylglutaryl-CoA reductase in mouse liver.

Lund E, Breuer O, Björkhem I. Lund E, et al. J Biol Chem. 1992 Dec 15;267(35):25092-7. J Biol Chem. 1992. PMID: 1460011 Free article.

3

On the mechanism of oxidation of cholesterol at C-7 in a lipoxygenase system.

Lund E, Diczfalusy U, Björkhem I. Lund E, et al. J Biol Chem. 1992 Jun 25;267(18):12462-7. J Biol Chem. 1992. PMID: 1618753 Free article.

4

Time course of oxysterol formation during in vitro oxidation of low density lipoprotein.

Dzeletovic S, Babiker A, Lund E, Diczfalusy U. Dzeletovic S, et al. Among authors: lund e. Chem Phys Lipids. 1995 Nov 17;78(2):119-28. doi: 10.1016/0009-3084(95)02489-6. Chem Phys Lipids. 1995. PMID: 8565112

5

The oxysterols cholest-5-ene-3 beta,4 alpha-diol, cholest-5-ene-3 beta,4 beta-diol and cholestane-3 beta,5 alpha,6 alpha-triol are formed during in vitro oxidation of low density lipoprotein, and are present in human atherosclerotic plaques.

Breuer O, Dzeletovic S, Lund E, Diczfalusy U. Breuer O, et al. Among authors: lund e. Biochim Biophys Acta. 1996 Jul 26;1302(2):145-52. doi: 10.1016/0005-2760(96)00052-5. Biochim Biophys Acta. 1996. PMID: 8695664

6

Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages.

Björkhem I, Andersson O, Diczfalusy U, Sevastik B, Xiu RJ, Duan C, Lund E. Björkhem I, et al. Among authors: lund e. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8592-6. doi: 10.1073/pnas.91.18.8592. Proc Natl Acad Sci U S A. 1994. PMID: 8078928 Free PMC article.

7

Novel pathways for elimination of cholesterol by extrahepatic formation of side-chain oxidized oxysterols.

Diczfalusy U, Lund E, Lütjohann D, Björkhem I. Diczfalusy U, et al. Among authors: lund e. Scand J Clin Lab Invest Suppl. 1996;226:9-17. Scand J Clin Lab Invest Suppl. 1996. PMID: 8981665 Review.

8

Quantitation of receptor ligands by mass spectrometry.

Lund EG, Diczfalusy U. Lund EG, et al. Methods Enzymol. 2003;364:24-37. doi: 10.1016/s0076-6879(03)64002-4. Methods Enzymol. 2003. PMID: 14631837 No abstract available.

9

Peroxisomal chain-shortening of thromboxane B2: evidence for impaired degradation of thromboxane B2 in Zellweger syndrome.

Diczfalusy U, Vesterqvist O, Kase BF, Lund E, Alexson SE. Diczfalusy U, et al. Among authors: lund e. J Lipid Res. 1993 Jul;34(7):1107-13. J Lipid Res. 1993. PMID: 8371058 Free article.

10

Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans.

Lund E, Andersson O, Zhang J, Babiker A, Ahlborg G, Diczfalusy U, Einarsson K, Sjövall J, Björkhem I. Lund E, et al. Arterioscler Thromb Vasc Biol. 1996 Feb;16(2):208-12. doi: 10.1161/01.atv.16.2.208. Arterioscler Thromb Vasc Biol. 1996. PMID: 8620334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,438 results

Search Page

Filters